Form 4 for ANIK Anika Therapeutics, Inc.

Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-04 · accession 0001171843-23-001480 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-03-07	2023-03-04	ANIK	Colleran David	EVP, GC, Corp Sec	M - OptEx	$0.00	+2,500	13.0K	+24%	$0
D	2023-03-07	2023-03-04	ANIK	Colleran David	EVP, GC, Corp Sec	F - Tax	$31.59	-734	12.3K	-6%	-$23.2K
D	2023-03-07	2023-03-04	ANIK	Colleran David	EVP, GC, Corp Sec	M - OptEx	$0.00	-2,500	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-03-04	M	A	2,500	$0.00	13,007	D	—	—	(F1) Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 4, 2020. (F2) Includes 640 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 13, 2022.
2	Common	Common Stock	2023-03-04	F	D	734	$31.59	12,273	D	—	—	(F3) Reflects an aggregate of 734 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 4, 2023. (F4) Reflects the closing price of ANIK common stock on March 3, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
3	Derivative	Restricted Stock Unit	2023-03-04	M	D	2,500	$0.00	0	D	$0.00 · — to —	2,500 Common Stock	(F5) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vested in three equal annual installments beginning March 4, 2021.